AI Fund is a startup studio building new AI companies from the ground up. Our companies bridge AI technology and applications, focusing on industries and problems that we believe move the world forward. Founded by Dr. Andrew Ng, our team merges a deep understanding of AI technology with a proven ability to start new ventures. AI Fund is uniquely positioned to build AI businesses that can make an immediate and decisive impact.

Founded in 1969 as a Silicon Valley start-up, the AMD journey began with dozens of employees focused on leading-edge semiconductor products. From those modest beginnings, AMD has grown into a global company of 10,000 people, achieving many important industry firsts along the way. AMD today develops high-performance computing and visualization products to solve some of the world’s toughest and most interesting challenges. There has never been a better time to be in the semiconductor industry, and we are ready to tackle the next 50 years with high-performance computing and graphics solutions that transform all of our lives.

Applied Materials is a world-wide largest Semiconductor and Display equipment manufacturer.

Algen is an Illumina-backed therapeutic discovery company that builds an intelligent platform to decode functional gene networks for drug discovery. Our smart CRISPR-based therapeutics engine utilizes CRISPR and machine learning to identify safe and efficacious cancer-specific targets.

AcuraStem is a fast growing startup company that was formed in 2016 to create an innovative precision medicine platform. We are a team of PhDs, professors, tech entrepreneurs, and successful drug company veterans employing the latest scientific breakthroughs to address one of the most challenging, but we believe tractable, health problems of our time — Amyotrophic Lateral Sclerosis (ALS). We are developing the best-in-class technology platform which consists of complex cellular models from ALS patient cells, and sophisticated assays which permit our scientists to model patient tissues in the laboratory. Using this advanced technology, we can evaluate the progression of disease and test existing FDA approved therapeutics or combinations of therapeutic approaches to find the most efficacious treatments possible to slow disease progression. AcuraStem has leveraged this platform to identify a novel ALS target and preclinical lead candidate which we are advancing to the clinic. AcuraStem also provides access to this technology platform to commercial and academic partners so that they can evaluate their therapeutic candidates under development.

Amyris is a leading company in the Industrial Biotech sector producing renewable chemicals across a number of markets, including specialty and performance ingredients, flavors and fragrances, pharmaceuticals, and nutraceuticals. Amyris was funded in 2003, and became a publicly traded company on NASDAQ since 2010, with current market cap above 400 million USD. Amyris’ headquarter is based on Emeryville, California, with around 500 full time employees (400-500 located in Emeryville), and has its manufacturing facilities in Brazil and a business office in China. Among our Board of Directors are influential Taiwanese biotech veterans Drs. Patrick Yang (楊育民 博士) and Frank Kung (孔繁建 博士). In 2016, Minister Tsung-Tsong Wu (吳政忠 政委) led a Taiwanese Biotech Delegation to visit our company. The core technology of our company is centering around Synthetic Biology and Metabolic Engineering in which President James Liao (廖俊智 院長) of Academia Sinica is the leading expert (in fact, two of his former students are currently working at Amyris).  

Applied Spectra, Inc. (ASI) is the leading supplier of analytical instruments using laser ablation (LA) technology. We’ve assembled a world-class scientific team whose members are truly the experts in LA-based chemical analysis. Our customers don’t just buy an instrument, they buy the very best scientific and technical support team.  ASI’s products simplify elemental chemical analysis, while delivering rapid, high-precision results that are environmentally friendly. Our technology offers compelling advantages over traditional chemical analysis methods, which are slower and frequently involve destroying the sample while generating toxic chemical waste by-products.

Aurora Healthcare US Corp (AHC) and its predecessor Aurora Imaging Technology Inc. (“Aurora or AHC”) was established in 1999 to develop a dedicated breast MRI system (BMRI) to be used initially as a superior breast cancer diagnostic system.  The technology’s key architect is Dr. Steven Harms, a world renown radiologist from Arkansas.   Aurora installed 80+ BMRI systems in hospitals and breast centers in the US, Europe and Asia with proven clinical benefits over general whole-body MRI systems. 
MRI has proven to have higher sensitivity and higher specificity than Mammography and Ultrasound in detecting breast cancers.  In the United States and Western World, it has primarily been used as a diagnostic tool due to cost and availability. AHC, along with several of its strategic partners (including Harvard Medical School and US-China Health Summit, a Massachusetts NGO linking US and China health leaders) developed a plan in relaunching the Aurora Breast MRI system as a screening modality by establishing Aurora Breast Centers (ABC) in hospitals initially in selected regions in China to ultimately expand ABCs throughout China. AHC has started its execution plan to establish operating team for the ABC business and build-up manufacturing capacity in China and Taiwan to meet the local installation and service demands. AHC will continue to allocate resources in R&D in the US especially in data science and AI development to narrow the gap of accessibility and affordability to expand the utilization and benefit of this high quality but expensive MRI clinical applications.   

AstraZeneca is a scientific research-based pharmaceutical company, which delivers life-changing therapeutics. It is a great place to work and employees are provided with great development opportunities to enhance their knowledge and career.

BioLegend enables life science discovery from research to cure by providing world-class quality products at an outstanding value, with superior customer service and technical support. Our focus on cutting-edge research and diagnostic reagents has established us as a global leader in immunology, cancer, neuroscience, cell biology, proteogenomics, stem cells, and other emerging segments. To learn more, visit www.biolegend.com

deeplearning.ai is an educational hub that provides online courses, resources, and a community for people who want to learn how to build or work with AI. The company was founded in 2017 by Dr. Andrew Ng.

Diodes Incorporated is a leading global manufacturer and supplier of high-quality application-specific standard products within the broad discrete, logic, analog and mixed-signal semiconductor markets. Diodes serves the consumer electronics, computing, communications, industrial, and automotive markets. Diodes’ products include diodes, rectifiers, transistors, Metal Oxide Semiconductor Field Effect Transistors (“MOSFET”), protection devices, function-specific arrays, logic, amplifiers and comparators, Hall-effect and temperature sensors, power management devices, including LED drivers, AC-DC converters and controllers, DC-DC switching and linear voltage regulators, and voltage references along with special function devices, such as USB power switches, load switches, voltage supervisors, and motor controllers.

Deep Health is developing AI-based spine navigation system

DRVISION is a Nikon affiliated company pioneering AI/machine learning and computer vision based image analysis software solutions.   With 50 issued US patients, DRVision technologies enable a new generation of intelligent (learning enabled) solutions for a wide range of applications in the past 2 decades.  DRVision’s measuring and inspection solutions can be found in the clean rooms of semiconductor fabs worldwide for IC production of smart phones, tablets, game consoles, PCs and electronics. DRVision’s advanced bioinformatics products are sold worldwide for microscopy image analysis in bio-science research, stem cells and health care and drug discovery fields. DRVision’s biomedical product development is significantly funded by US government grants (over US$10 million budget) collaborating with world class researchers from Harvard medical school, University of Southern California, Tokyo University and Osaka University. DRVision have continuously delivered annual profits since its inception in 1999.

Equalearning is a software development company in the high-tech San Diego only 5 mins from the beach.  We focused on three fields: 1. Interactive Mobile learning platform for global education market based on .Net and Android/iOS technologies. 2. Business training and event management system with integrated hardware IOT solutions 3. Patented Edge computing EDGE server for remote education, global mission and charity organizations. Our focused markets are: US, Taiwan, South Asia and Africa. We are a young and energetic start-up company that everyone is deeply involved in product development, customer solution creation, market development and strategic business growth. We are looking for passionate professionals that are seeking opportunities to challenge yourself for problem solving and make real impacts to the international markets.  You will receive training and take on global competing projects that challenge every aspect of your capabilities: your oral presentation, your analytical and critical thinking, team work/soft skill, attention to the technical and human UI/UX details.  Our culture is to adapt changes quickly: model the system, find the gap,  learn and perform in 10X speeds high efficiency. But when we are off the work, we are like a family; we go BBQ, boating, go to ball games together and we have a weekly sharing lunch inviting charity organization clients. It’s a work smart, play hard company that grows with each of our employee. 

Fortemedia, Inc. is a worldwide provider of advanced voice processing technologies to enhance human-to-human and human-to-machine voice communication efficiencies.  We strive to provide silicon solutions and leading edge technologies to enhance user experience and to promote speech communication efficiencies in challenging acoustic environments. Our voice processing IC’s, hardware, and software components have been widely deployed in mobile devices, laptops, voice-over-IP conferencing terminals, webcam devices, and automotives.  We pioneered Small Array Microphone (SAM®) voice processing technologies and successfully commercialized it into mobile-phone communications. Backed by our company’s strong focus in Research and Development, Fortemedia has over 75 patents worldwide with 20 pending. The company is headquartered in Santa Clara, California, with global operations and offices throughout Asia, as well as sales support in Europe to ensure continuous customer success.

Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.

We are a quality-certified CRO that adapts responsively to change so you can make informed decisions that minimize risk and drive better outcomes. Built on decades of clinical development leadership and expertise, we support the drug development efforts of pharmaceutical and biotech companies through advanced in-home patient visits, data management & biostatistics, medical writing, regulatory consulting, clinical pharmacology, and clinical operations.

Jasper Display Corp., operations started in 2010, is a leading designer of SLM (Spatial Light Modulators) and has successfully developed and brought to the marketplace several new, very high speed Full HD (FHD) microdisplays and a microdisplay controller, establishing a line of new LCoS products to support color-sequential single-microdisplay operated at FHD resolution and high frame rate. In addition, Jasper Display has the world’s smallest Ultra HD (UHD) microdisplay in the world. Jasper Display’s newest addition, the OCM, will now add an ASIC controller to drive the full line of microdisplays from FHD to UHD microdisplays.

Based in San Diego, Kneron Inc. is a start-up dedicated to local/edging AI solutions. Kneron was the winner of Tengfei Award by Tencent and won the third place in Innovation Competition of International Talents, Silicon Valley Division.

Lovett Group, founded in 1980, is a preeminent residential and commercial real estate developer with projects in Houston, Dallas and Austin Texas.

Due to its solid track record in residential development, the Group enjoys close relationships with the City of Houston, the City of Dallas, the City of Addison, the City of Round Rock and other governing agencies. Its residential communities have been distinguished by many awards and accolades including First Place in the 2011 ULI Development of Distinction Award.

For more information, please view: lovetthomes.com; intownhomes.com

In 1994, the Group created its award-winning commercial real estate arm, Lovett Commercial, which develops both creative urban retail and suburban supercenter projects. Established relationships with some of the largest retailers in Texas and the U.S., including Walmart, Walgreens, HEB, CVS, WholeFoods among others.

First Place recipient of the 2018 ULI Development of Distinction Award for Sawyer Yards and the 2016 GoodBrick Award for B&B Butchers.

Group has access to ample credit lines (committed credit lines in excess of US$600 million) with deep relationships with local and national lenders including Wells Fargo, US Bank, Prosperity Bank, Cadence Bank, among others.

For more information, please view: lovetthomes.com; intownhomes.com

Microsoft Corporation is an American multinational corporation headquartered in Redmond, Washington, that develops, manufactures, licenses, supports and sells computer software, consumer electronics and personal computers and services.

mFluiDx is aiming to develop the world’s lowest cost, automated point-of-care DNA diagnostic assay for small clinics.  In small clinics, such as primary care out-patient clinics, disease diagnosis is typically done by observing symptoms or using paper-strip antibody tests. However, these methods have poor sensitivity compared to DNA diagnostics.  Highly sensitive molecular DNA tests (PCR) are not often used because of cost and the need to send tests off-site resulting in a slow turnaround time (several days).  mFluiDx is a UC Berkeley startup developing Gates Foundation funded low-cost microfluidic diagnostic technologies capable of on-site multi-target isothermal DNA detection of infectious diseases with simple operation and ~100X lower cost than PCR setups. We aim to create assays that can be deployed in decentralized settings, are as simple and cheap as paper tests, yet have DNA level sensitivity for onsite diagnosis.  mFluiDx has been selected as one of the top 20 finalists from a global competition of 900 startups at Techcrunch’s Startup Battlefield, it has participated the world’s leading biotech startup accelerator (Indiebio Accelerator). IMore info can be found in this video link (CITRIS Foundry demo day pitch): https://youtu.be/WSEKyGikUKU 

Mucker Capital is early stage venture fund investing in companies powering a digital world, while our MuckerLab is top-tier accelerator in US. Based in „Silicon Beach“ California, Mucker provides not only capital but also business and technical support for startups, including those who are outside Silicon Valley.

In 1999 sparked the growth of the PC gaming market, redefined modern computer graphics, and revolutionized parallel computing. More recently, GPU deep learning ignited modern AI — the next era of computing — with the GPU acting as the brain of computers, robots, and self-driving cars that can perceive and understand the world.

NanoCellect is the world leader for bench top flow cytometer and fluorescene-actived-cell-sorter (FACS) based on microfluidic technology.  In its product pipeline, the company is developing the world's first image-guided cell sorter based on machine learning and AI.  The new product will be released in 2020.

Onyx Healthcare USA, Inc. is a subsidiary of the ASUS Group and a professional medical technology company with over 15 years of design and manufacturing experience serving world class medical device OEM.  As an ISO13485 certified and FDA registered device manufacturer, the company provides custom design and manufactures medical grade (UL/EN60601-1 | CE/FCC Class B) computer products for various world class medical device customers.

Our product portfolio focuses on surgical navigation, imaging diagnostic, lab 4.0, Internet of Things (IoT), mobile nursing, patient engagement, patient surveillance, and telemedicine turnkey solutions in various clinical applications. We are capable of global supply, and are committed to uncompromising quality and exceptional service to ensure efficiencies to all our medical customers and system integration partners.

Progressive Electric Utiity responsible for the transmission and distribution of electricty. Oncor is a industry leader in data analytics. 

Pfizer Inc. is an American multinational pharmaceutical corporation headquartered in New York City,[3] with its research headquarters in Groton, Connecticut. It is one of the world's largest pharmaceutical companies.[4] It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004.[5] Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue

PreNav develops drones, software, and ML/AI algorithms for the inspection of civil infrastructure (bridges, dams, power plants, buildings). The company’s technology captures high fidelity digital twins that are analyzed with deep learning to inspect for cracks, corrosion, and changes over time.

QT Medical, Inc. is a medical device startup incorporated in 2013. With innovative technologies, we aim to make high quality 12-lead electrocardiogram (ECG) available to everyone. QT ECG™, the first product of QT Medical, is the world's most compact 12-lead ECG system. With its simplicity, ease of use, familiar interface by mobile technology, QT ECG™ is bringing hospital-quality 12-lead ECG to homes. It is optimized for high risk patients who just had coronary artery bypass graft (CABG) surgery, or percutaneous coronary intervention (PCI, i.e. coronary stent). It is also designed for home use by patients with chronic heart failure and arrhythmias.

Syneurx is pioneering and developing revolutionary, completely new classes of drug to answer the unmet medical needs in central nervous systen (CNS) disorders.  Our candidate drugs hold great promise to fast track the development process and reach a dominant position in the CNS drug market quickly. The candidates in our pipeline represent a rare opportunity with low risk and potential success. 

STMicroelectronics is a world leader in providing the semiconductor solutions that make a positive contribution to people’s lives, today and into the future.  ◦Among the world’s largest semiconductor companies  ◦A leading Integrated Device Manufacturer delivering solutions that are key to Smart Driving, Smart Industry, Smart Home & City and Smart Things  ◦A leading technology innovator: ~7,400 people working in R&D and product design, ~18,000 patents, ~ 9,600 patent families and ~ 550 new patent filings in 2018  ◦An unwavering commitment to sustainability   ◦Corporate Headquarters: Geneva, Switzerland  ◦President and CEO: Jean-Marc Chery  ◦2018 revenues: $9.66 billion  ◦~46,000 employees worldwide  ◦80 sales & marketing offices in 35 countries  ◦More than 100,000 customers worldwide  ◦11 main manufacturing sites  ◦Public since 1994: shares traded on the New York Stock Exchange (NYSE: STM), Euronext Paris, and Borsa Italiana  ◦Created as SGS-THOMSON Microelectronics in June 1987, from merger of SGS Microelettronica (Italy) and Thomson Semiconducteurs (France)  ◦Renamed STMicroelectronics in May 1998 

Start up that is helping large customers (Cisco, LinkedIn etc..) to manage their data centers using home grown DCIM Software

Sunbird Software is changing the way data centers are being managed. With a focus on real user scenarios for real customer problems, we help data center operators manage tasks and processes faster and more efficient than ever before, while saving costs and improving availability. We strive to eliminate the complexity they have been forced to accept from point tools and home grown applications, removing the dependency on emails and spreadsheets to transform the delivery of data center services. Sunbird delivers on this commitment with unexpected simplicity through products that are easy to find, buy, deploy, use, and maintain. Our solutions are rooted in our deep connections with our customers who share best practices and participate in our user groups and product development process.

Spokeo is a people intelligence service that helps you search, connect, and know who you are dealing with. You can use it to find old friends, identify unknown callers, or research your date. Professionals use it to find new customers or to prevent fraud. Knowledge is a quick search away.

Taiwania Capital Management Corporation ("Taiwania Capital") founded in 2017, is a Venture Capital firm based in Taiwan and Silicon Valley. We are Taiwan's national investment arm and are backed with government's resources and support. 

The goals of Taiwania Capital are to establish partnership with worldwide companies and to boost Taiwan's economic growth. By partnering with the cutting edge startups, we stimulate innovation in sectors including information and communication technology (ICT), biotech, material, energy, new agriculture, etc.

We connect startups to seasoned entrepreneurs and industry leaders. Taiwania Capital's CEO David Weng has more than 20 years of investment experience in Silicon Valley.  Our mentor group includes entrepreneurs with million-dollar and billion-dollar exits experiences from software and hardware industries. 

Taiwania Capital's name comes from "Taiwania" which is one of the largest tree species in Asia. It was first discovered in Taiwan more than one hundred years ago and named after Taiwan.

For over 30 years, Telco has been bringing together the world's largest selection of quality motion control assemblies, components, and parts—coupled with the industry's top experts and engineers—to create optimized solutions for every project.

The Biomedical Research Institute of Southern California (BRISC) is a 501 (c) (3) exempt nonprofit organization, dedicated to scientific research aimed at curing or preventing human disease. We are located in San Diego North County, California.

Taboola enables over 1.4B people to discover what’s interesting and new at the moments they’re most ready to explore. Powered by Deep Learning, AI, and a large dataset, Taboola’s discovery platform creates new monetization, audience and engagement opportunities for digital properties, including publishers, mobile carriers and handset manufacturers. Advertisers use Taboola to reach their target audience when they’re most receptive to new messages, products and services.

Some of the most innovative digital properties in the world have long term, exclusive relationships with Taboola, including CNBC, NBC News, USA TODAY, BILD, Sankei, Huffington Post, Microsoft, Business Insider, The Independent, and Le Figaro. Taboola, now over 1,000 people globally, is headquartered in New York City with offices in Mexico City, São Paulo, Los Angeles, London, Berlin, Madrid, Paris, Tel Aviv, New Delhi,Bangkok, Beijing, Shanghai, Istanbul, Seoul, Tokyo, and Sydney.

Tubis Technology Inc. has been developing mmWave phased-array antenna for 5G cellular and Satellite market for the past 5 years. The area of focus and expertise is Semiconductor Design – CMOS and GaAs, Packaging Technology – antenna in package and silicon in package, RF systems technology – RF IC design, phased-array technology, beam forming

Vivo Capital is a healthcare focused investment firm formed in 1996 with over $3 billion under management. Vivo Capital is currently making investments from its $750M eighth fund into promising private and public healthcare companies in the U.S. and Greater China, from its $635M Opportunity fund into promising public healthcare companies, and from its $100M PANDA fund into promising early-stage innovative healthcare companies. Vivo employs a unique multi-pronged strategy of identifying and working with companies with promising therapeutic products at all stages in the U.S. and revenue stage companies in Greater China. Vivo Capital has offices in Palo Alto, California, Beijing, Shanghai and Taipei. With extensive scientific expertise and operating experience in healthcare, Vivo makes investment decisions for the Funds and helps its portfolio companies develop corporate strategy, facilitate strategic alliances including cross-border partnerships, recruit management, and acquire new products and technologies to accelerate growth. Vivo’s current portfolio includes more than 80 private and public biotechnology companies in the areas of biopharmaceuticals, specialty pharmaceuticals, and medical devices.